Bayer gets EU CHMP nod for precision oncology treatment larotrectinib

World |  News | 0 Comment | 02 Aug, 2019

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended Bayer’s precision oncology treatment larotrectinib for marketing authorizati...Read more

Access Scientific signs sales agreement with Smiths Medical

World |  News | 0 Comment | 02 Aug, 2019

Access Scientific, LLC, a leading provider of extended dwell and midline catheters, announced the signing of a sales agreement with Smiths Medical to sell the POWERWAND™ product line ...Read more

Novo Nordisk, e-therapeutics extend Type 2 diabetes research pact

World |  News | 0 Comment | 02 Aug, 2019

UK based firm e-therapeutics has announced that it has signed an extension to its existing research collaboration with Novo Nordisk in the type 2 diabetes space. To date, the companies have...Read more

Malaria No More adds two leaders to its board

World |  News | 0 Comment | 01 Aug, 2019

Malaria No More has announced the appointment of Uday Shankar, Chairman of Star and Disney India and President of The Walt Disney Company’s Asia Pacific Unit, and Kathy Park, Managing...Read more

Novanta completes acquisition of ARGES

World |  News | 0 Comment | 01 Aug, 2019

Novanta, a trusted technology partner to medical and advanced industrial equipment manufacturers has completed its acquisition of ARGES GmbH, based in Wackersdorf, Germany. ARGES develops ...Read more

FDA approves new monotherapy indication for Merck’s KEYTRUDA

World |  News | 0 Comment | 01 Aug, 2019

Merck known as MSD outside the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherap...Read more

WHO Endorsement of Simpler Drug Treatment for Blood Pressure Will Save Lives: George Institute

World |  News | 0 Comment | 01 Aug, 2019

The George Institute for Global Health has announced that it welcomes the addition of fixed-dose combinations (FDCs) of blood pressure (BP) lowering drugs to the World Health Organization&r...Read more

USFDA approves Bayer’s darolutamide for Prostate Cancer

World |  News | 0 Comment | 01 Aug, 2019

The U.S. Food and Drug Administration (FDA) has approved darolutamide, a non-steroidal androgen receptor inhibitor (ARi), under the brand name Nubeqa®. The FDA approval is for the trea...Read more

FDA clears new indications for existing Lyme disease tests

World |  News | 0 Comment | 01 Aug, 2019

The U.S. Food and Drug Administration recently cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared are the fi...Read more

Pfizer acquires array biopharma

World |  News | 0 Comment | 31 Jul, 2019

Pfizer Inc. has announced the successful completion of its acquisition of Array BioPharma Inc., advancing breakthrough science for the discovery, development and commercialization of target...Read more

Hillrom introduces new technology in fight against Diabetic Retinopathy

World |  News | 0 Comment | 30 Jul, 2019

Hillrom announced that its latest innovation in vision screening and diagnostics with the introduction of the Welch Allyn® RetinaVue® 700 Imager handheld retinal camera, part of the...Read more

Roche expands Global Access Program beyond HIV

World |  News | 0 Comment | 30 Jul, 2019

Roche has announced that the Global Access Program is expanding beyond HIV, to include Mycobacterium tuberculosis (MTB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV) for ...Read more

Hikma launches Cisplatin Injection

World |  News | 0 Comment | 29 Jul, 2019

Hikma Pharmaceuticals PLC the multinational pharmaceutical company, has launched Cisplatin Injection, 1mg/mL in 50mL and 100mL vials, in the United States through its US affiliate, Hikma Ph...Read more

Hikma, Civica to reduce generic drug shortages in the US

World |  News | 0 Comment | 29 Jul, 2019

Hikma Pharmaceuticals PLC,the multinational generic pharmaceutical company and Civica Rx (Civica, Inc.) have announced a five-year agreement to manufacture and supply Civica’s growing...Read more

Are you up-to-date with the new LABORATORY TRENDS in 2019?

World |  News | 1 Comment | 26 Jul, 2019

The medical laboratories market is growing rapidly in the Asia-Pacific region mainly due to the growing awareness about medical testing services, government support to improve the healthcar...Read more

Curza gets $5.25M funding from the Novo Holdings

World |  News | 0 Comment | 26 Jul, 2019

Curza, a privately-held small-molecule drug development company focused on the discovery and development of novel therapeutics to address the high unmet need of multi-drug resistant bacteri...Read more

Allergan voluntarily recalls BIOCELL® textured breast implants

World |  News | 0 Comment | 26 Jul, 2019

Allergan plc (NYSE: AGN) has announced a voluntary worldwide recall of BIOCELL® textured breast implants and tissue expanders. Allergan is taking this action as a pr...Read more

Dassault Systèmes extends collaboration with FDA

World |  News | 0 Comment | 25 Jul, 2019

Dassault Systèmes has announced the five-year extension of its collaboration with the U.S. Food and Drug Administration.  The 3DEXPERIENCE platform will be used t...Read more